Trials / Completed
CompletedNCT02829333
The Effect of Anesthetic Technique on VEGF-C and PGE2
Effect of Anesthetic Technique on Serum Vascular Endothelial Growth Factor C and Prostaglandin E2 in Women Undergoing Surgery for Uterine Leiomyomas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- General Hospital of Ningxia Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to verify the effect of anesthetic technique on the change of postoperative serum vascular endothelial growth factor C and prostaglandin E2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.
Detailed description
Uterine leiomyomas is the most common benign tumor of uterus, the most common tumor in women as well. Like many other forms of tumor, it requires an independent blood supply to enlarge. This process, angiogenesis, is mediated by vascular endothelial growth factor C (VEGF-C) and prostaglandin E2 (PGE2). Several studies have confirmed that VEGF-C has a high level in patients with uterine leiomyomas, which has also been demonstrated that it was related to occurrence and growth of uterine leiomyomas because it's capable of promoting angiogenesis, mitogenic, and vascular permeability-enhancing activities. Also, some researchers suggested that suppression of prostaglandin synthesis (including PGE2) via cyclooxygenase type-2 (COX-2) enzyme inhibition may reduce the incidence of some tumor. The aim of this study is to verify the effect of anesthetic technique on the change of postoperative serum VEGF-C and PGE2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | general anesthesia and patient controlled intravenous analgesia | Patients receive general anesthesia intraoperative period and continuous intravenous analgesia postoperation |
| OTHER | spinal anesthesia and continuous postoperative epidural analgesia | Patients receive spinal anesthesia intraoperative period and continuous epidural analgesia postoperation |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2016-07-12
- Last updated
- 2020-01-22
Source: ClinicalTrials.gov record NCT02829333. Inclusion in this directory is not an endorsement.